Comparison 5. Oestrogen + other treatments versus other treatments.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Number with incontinence (women's observations)	3		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
1.1 oestrogen + PFMT vs PFMT	1		Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
1.2 Vaginal oestrogen + TVT vs TVT	2		Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
2 Number with incontinence not improved (women's observations)	1		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
2.1 oestrogen + PPA vs PPA	1		Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
3 Number of pad changes over 24 hours	1		Mean Difference (IV, Fixed, 95% CI)	Totals not selected
3.1 oestrogen + PPA vs PPA	1		Mean Difference (IV, Fixed, 95% CI)	0.0 [0.0, 0.0]
4 Number of voids over 24 hours	2		Mean Difference (IV, Fixed, 95% CI)	Totals not selected
4.1 oestrogen + PPA vs PPA	1		Mean Difference (IV, Fixed, 95% CI)	0.0 [0.0, 0.0]
4.2 detrusitol + vaginal oestrogen vs detrusitol m	1		Mean Difference (IV, Fixed, 95% CI)	0.0 [0.0, 0.0]
5 Pad test weights	1		Mean Difference (IV, Fixed, 95% CI)	Totals not selected
5.1 oestrogen + PPA vs PPA	1		Mean Difference (IV, Fixed, 95% CI)	0.0 [0.0, 0.0]
6 Adverse effects	2		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
6.1 oestrogen + PPA vs PPA	1		Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
6.2 oestrogen + PFMT vs PFMT	1		Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]